Stuart James McKinnon
Associate Professor of Ophthalmology
Stuart J. McKinnon, MD, PhD, specializes in the diagnosis and treatment of glaucoma and cataract. His areas of expertise include open and closed angle glaucomas, neovascular and other secondary glaucomas, and juvenile glaucoma. He is experienced in all forms of anterior segment procedures including laser therapy and filtering surgeries for glaucoma, as well as cataract surgery. He is integrally involved in the teaching of medical students, residents, and fellows. McKinnon's research activities include NIH-sponsored exploration of the basic mechanisms of retinal cell death in glaucoma. Other research areas include neuroprotective glaucoma therapies, non-invasive imaging of glaucoma damage, and relationships between glaucoma and other chronic neurodegenerations such as Alzheimer's disease.
Current Appointments & Affiliations
- Associate Professor of Ophthalmology, Ophthalmology, Glaucoma, Ophthalmology 2015
- Associate Professor in Neurobiology in Neurobiology, Neurobiology, Basic Science Departments 2015
Contact Information
- Box 3802 Erwin Road, Durham, NC 27710
- Box 3802 Med Ctr, Durham, NC 27710
-
stuart.mckinnon@duke.edu
(919) 684-8850
- Background
-
Education, Training, & Certifications
- Associate Professor, Ophthalmology, University of Texas Medical School, Houston 2004 - 2005
- Assistant Professor, Ophthalmology, University of Texas Medical School, Houston 1999 - 2004
- Assistant Professor, Ophthalmology, Johns Hopkins University 1996 - 1999
- Glaucoma Fellow, Ophthalmology, Johns Hopkins University 1995 - 1996
- Resident, Ophthalmology, Louisiana State University, Shreveport 1991 - 1995
- Intern, Baptist Medical Center, Birmingham 1990 - 1991
- M.D., Louisiana State University 1990
- Ph.D., University of New Orleans 1990
- M.S., University of New Orleans 1986
- B.S., University of Massachusetts - Amherst 1984
-
Duke Appointment History
- Associate Professor of Ophthalmology, Ophthalmology, Glaucoma, Ophthalmology 2005 - 2015
- Associate Professor in Neurobiology, Neurobiology, Basic Science Departments 2005 - 2015
- Instructor, Temporary in the Department of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery, Ophthalmology 2005
- Recognition
-
Awards & Honors
- Research
-
Selected Grants
- Neuroinflammation: the role of lymphocytes in glaucoma awarded by BrightFocus Foundation 2014 - 2016
- The Retroject Device: A Novel Approach to Glaucoma Drug Delivery awarded by Retroject, Inc 2014 - 2015
- Autophagic Lysosomal Pathway and Glaucoma awarded by National Institutes of Health 2010 - 2015
- Mechanisms of RGC Loss in a Murine Model of Glaucoma awarded by National Institutes of Health 2009 - 2012
- Retinal Ganglion Cell Apoptosis in Experimental Glaucoma awarded by National Institutes of Health 2005 - 2011
-
External Relationships
- Envolve Vision (division of Centene Corporation)
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Hirt, Joshua, Kris Porter, Angela Dixon, Stuart McKinnon, and Paloma B. Liton. “Contribution of autophagy to ocular hypertension and neurodegeneration in the DBA/2J spontaneous glaucoma mouse model.” Cell Death Discov 4 (2018): 14. https://doi.org/10.1038/s41420-018-0077-y.Full Text Link to Item
-
Li, Guorong, Sina Farsiu, Jianming Qiu, Angela Dixon, Chunwei Song, Stuart J. McKinnon, Fan Yuan, Pedro Gonzalez, and W Daniel Stamer. “Disease progression in iridocorneal angle tissues of BMP2-induced ocular hypertensive mice with optical coherence tomography.” Mol Vis 20 (2014): 1695–1709.Link to Item
-
Liu, Shuang, Bingqing Wang, Biwei Yin, Thomas E. Milner, Mia K. Markey, Stuart J. McKinnon, and Henry G. Rylander. “Retinal nerve fiber layer reflectance for early glaucoma diagnosis.” J Glaucoma 23, no. 1 (January 2014): e45–52. https://doi.org/10.1097/IJG.0b013e31829ea2a7.Full Text Link to Item
-
Gardiner, Stuart K., Shaban Demirel, Mae O. Gordon, and Michael A. Kass. “Seasonal Changes in Visual Field Sensitivity and Intraocular Pressure in the Ocular Hypertension Treatment Study.” Ophthalmology 120, no. 4 (April 2013): 724–30. https://doi.org/10.1016/j.ophtha.2012.09.056.Full Text
-
Gardiner, Stuart K., Shaban Demirel, Carlos Gustavo De Moraes, Jeffrey M. Liebmann, George A. Cioffi, Robert Ritch, Mae O. Gordon, and Michael A. Kass. “Series Length Used during Trend Analysis Affects Sensitivity to Changes in Progression Rate in the Ocular Hypertension Treatment Study.” Investigative Opthalmology & Visual Science 54, no. 2 (February 15, 2013): 1252–1252. https://doi.org/10.1167/iovs.12-10218.Full Text
-
Samuels, Brian C., Nathan M. Hammes, Philip L. Johnson, Anantha Shekhar, Stuart J. McKinnon, and R Rand Allingham. “Dorsomedial/Perifornical hypothalamic stimulation increases intraocular pressure, intracranial pressure, and the translaminar pressure gradient.” Invest Ophthalmol Vis Sci 53, no. 11 (October 23, 2012): 7328–35. https://doi.org/10.1167/iovs.12-10632.Full Text Link to Item
-
Mansberger, Steven L., Mae O. Gordon, Henry Jampel, Anjali Bhorade, James D. Brandt, Brad Wilson, and Michael A. Kass. “Reduction in Intraocular Pressure after Cataract Extraction: The Ocular Hypertension Treatment Study.” Ophthalmology 119, no. 9 (September 2012): 1826–31. https://doi.org/10.1016/j.ophtha.2012.02.050.Full Text
-
McKinnon, Stuart J. “The cell and molecular biology of glaucoma: common neurodegenerative pathways and relevance to glaucoma.” Invest Ophthalmol Vis Sci 53, no. 5 (May 4, 2012): 2485–87. https://doi.org/10.1167/iovs.12-9483j.Full Text Link to Item
-
De Moraes, Carlos Gustavo, Shaban Demirel, Stuart K. Gardiner, Jeffrey M. Liebmann, George A. Cioffi, Robert Ritch, Mae O. Gordon, and Michael A. Kass. “Effect of Treatment on the Rate of Visual Field Change in the Ocular Hypertension Treatment Study Observation Group.” Investigative Opthalmology & Visual Science 53, no. 4 (April 2, 2012): 1704–1704. https://doi.org/10.1167/iovs.11-8186.Full Text
-
Brandt, James D., Mae O. Gordon, Feng Gao, Julia A. Beiser, J Phillip Miller, and Michael A. Kass. “Adjusting Intraocular Pressure for Central Corneal Thickness Does Not Improve Prediction Models for Primary Open-Angle Glaucoma.” Ophthalmology 119, no. 3 (March 2012): 437–42. https://doi.org/10.1016/j.ophtha.2011.03.018.Full Text
-
Demirel, Shaban, Carlos Gustavo V. De Moraes, Stuart K. Gardiner, Jeffrey M. Liebmann, George A. Cioffi, Robert Ritch, Mae O. Gordon, and Michael A. Kass. “The Rate of Visual Field Change in the Ocular Hypertension Treatment Study.” Investigative Opthalmology & Visual Science 53, no. 1 (January 25, 2012): 224–224. https://doi.org/10.1167/iovs.10-7117.Full Text
-
Gao, Feng, J Philip Miller, Chengjie Xiong, Julia A. Beiser, and Mae Gordon. “A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome.” Statistical Methods & Applications 20, no. 1 (March 2011): 83–100. https://doi.org/10.1007/s10260-010-0150-z.Full Text
-
Myers, J. S. “The Utility of the Monocular Trial: Data from the Ocular Hypertension Treatment Study.” Yearbook of Ophthalmology 2011 (January 2011): 97–100. https://doi.org/10.1016/j.yoph.2011.03.025.Full Text
-
Artes, Paul H. “Longitudinal and Cross-sectional Analyses of Visual Field Progression in Participants of the Ocular Hypertension Treatment Study.” Archives of Ophthalmology 128, no. 12 (December 13, 2010): 1528–1528. https://doi.org/10.1001/archophthalmol.2010.292.Full Text
-
Kipfer-Kauer, Anna, Stuart J. McKinnon, Beatrice E. Frueh, and David Goldblum. “Distribution of amyloid precursor protein and amyloid-beta in ocular hypertensive C57BL/6 mouse eyes.” Curr Eye Res 35, no. 9 (September 2010): 828–34. https://doi.org/10.3109/02713683.2010.494240.Full Text Link to Item
-
Caprioli, Joseph, and Anne L. Coleman. “Blood Pressure, Perfusion Pressure, and Glaucoma.” American Journal of Ophthalmology 149, no. 5 (May 2010): 704–12. https://doi.org/10.1016/j.ajo.2010.01.018.Full Text
-
Barnett, Edward M., Aldo Fantin, Bradley S. Wilson, Michael A. Kass, and Mae O. Gordon. “The Incidence of Retinal Vein Occlusion in the Ocular Hypertension Treatment Study.” Ophthalmology 117, no. 3 (March 2010): 484–88. https://doi.org/10.1016/j.ophtha.2009.08.022.Full Text
-
Stein, Joshua D., Allison N. McCoy, Sanjay Asrani, Leon W. Herndon, Paul P. Lee, Stuart J. McKinnon, R Rand Allingham, and Pratap Challa. “Surgical management of hypotony owing to overfiltration in eyes receiving glaucoma drainage devices.” J Glaucoma 18, no. 8 (October 2009): 638–41. https://doi.org/10.1097/IJG.0b013e31819aa4e0.Full Text Link to Item
-
Radhakrishnan, Sunita, Harry A. Quigley, Henry D. Jampel, David S. Friedman, Sameer I. Ahmad, Nathan G. Congdon, and Stuart McKinnon. “Outcomes of surgical bleb revision for complications of trabeculectomy.” Ophthalmology 116, no. 9 (September 2009): 1713–18. https://doi.org/10.1016/j.ophtha.2009.04.003.Full Text
-
Walsh, Molly M., Haiqing Yi, Julie Friedman, Kyoung-In Cho, Nomingerel Tserentsoodol, Stuart McKinnon, Kelly Searle, Andrew Yeh, and Paulo A. Ferreira. “Gene and protein expression pilot profiling and biomarkers in an experimental mouse model of hypertensive glaucoma.” Exp Biol Med (Maywood) 234, no. 8 (August 2009): 918–30. https://doi.org/10.3181/0811-RM-344.Full Text Link to Item
-
Bhorade, Anjali M., Mae O. Gordon, Brad Wilson, Robert N. Weinrab, and Michael A. Kass. “Variability of Intraocular Pressure Measurements in Observation Participants in the Ocular Hypertension Treatment Study.” Ophthalmology 116, no. 4 (April 2009): 717–24. https://doi.org/10.1016/j.ophtha.2008.12.036.Full Text
-
McKinnon, Stuart J., Cassandra L. Schlamp, and Robert W. Nickells. “Mouse models of retinal ganglion cell death and glaucoma.” Exp Eye Res 88, no. 4 (April 2009): 816–24. https://doi.org/10.1016/j.exer.2008.12.002.Full Text Link to Item
-
“The Accuracy and Clinical Application of Predictive Models for Primary Open-Angle Glaucoma in Ocular Hypertensive Individuals.” Ophthalmology 115, no. 11 (November 2008): 2030–36. https://doi.org/10.1016/j.ophtha.2008.06.036.Full Text
-
“Diabetes and Glaucoma.” Archives of Ophthalmology 126, no. 5 (May 27, 2008): 746–746. https://doi.org/10.1001/archopht.126.5.746-b.Full Text
-
Gordon, Mae O. “Is a History of Diabetes Mellitus Protective Against Developing Primary Open-angle Glaucoma?” Archives of Ophthalmology 126, no. 2 (February 1, 2008): 280–280. https://doi.org/10.1001/archophthalmol.2007.35.Full Text
-
McKinnon, Stuart J., Lawrence D. Goldberg, Patti Peeples, John G. Walt, and Thomas J. Bramley. “Current management of glaucoma and the need for complete therapy.” Am J Manag Care 14, no. 1 Suppl (February 2008): S20–27.Link to Item
-
Keltner, John L., Chris A. Johnson, Kimberly E. Cello, Shannan E. Bandermann, Juanjuan Fan, Richard A. Levine, Michael A. Kass, and Mae O. Gordon. “Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS).” Journal of Glaucoma 16, no. 8 (December 2007): 665–69. https://doi.org/10.1097/ijg.0b013e318057526d.Full Text
-
“Validated Prediction Model for the Development of Primary Open-Angle Glaucoma in Individuals with Ocular Hypertension.” Ophthalmology 114, no. 1 (January 2007): 10-19.e2. https://doi.org/10.1016/j.ophtha.2006.08.031.Full Text
-
Budenz, Donald L., Douglas R. Anderson, William J. Feuer, Julia A. Beiser, Joyce Schiffman, Richard K. Parrish II, Jody R. Piltz-Seymour, Mae O. Gordon, and Michael A. Kass. “Detection and Prognostic Significance of Optic Disc Hemorrhages during the Ocular Hypertension Treatment Study.” Ophthalmology 113, no. 12 (December 2006): 2137–43. https://doi.org/10.1016/j.ophtha.2006.06.022.Full Text
-
Herman, David C., Mae O. Gordon, Julia A. Beiser, Leo T. Chylack, Kathleen A. Lamping, Oliver D. Schein, Joern B. Soltau, and Michael A. Kass. “Topical Ocular Hypotensive Medication and Lens Opacification: Evidence From the Ocular Hypertension Treatment Study.” American Journal of Ophthalmology 142, no. 5 (November 2006): 800-810.e1. https://doi.org/10.1016/j.ajo.2006.06.052.Full Text
-
KELTNER, J., C. JOHNSON, D. ANDERSON, R. LEVINE, J. FAN, K. CELLO, H. QUIGLEY, D. BUDENZ, R. PARRISH, and M. KASS. “The Association between Glaucomatous Visual Fields and Optic Nerve Head Features in the Ocular Hypertension Treatment Study.” Ophthalmology 113, no. 9 (September 2006): 1603–12. https://doi.org/10.1016/j.ophtha.2006.05.061.Full Text
-
Levine, Richard A., Shaban Demirel, Juanjuan Fan, John L. Keltner, Chris A. Johnson, and Michael A. Kass. “Asymmetries and Visual Field Summaries as Predictors of Glaucoma in the Ocular Hypertension Treatment Study.” Investigative Opthalmology & Visual Science 47, no. 9 (September 1, 2006): 3896–3896. https://doi.org/10.1167/iovs.05-0469.Full Text
-
Kymes, Steven M., Michael A. Kass, Douglas R. Anderson, J Philip Miller, and Mae O. Gordon. “Management of Ocular Hypertension: A Cost-effectiveness Approach From the Ocular Hypertension Treatment Study.” American Journal of Ophthalmology 141, no. 6 (June 2006): 997-1008.e3. https://doi.org/10.1016/j.ajo.2006.01.019.Full Text
-
Ivanov, Dmitry, Galina Dvoriantchikova, Lubov Nathanson, Stuart J. McKinnon, and Valery I. Shestopalov. “Microarray analysis of gene expression in adult retinal ganglion cells.” Febs Lett 580, no. 1 (January 9, 2006): 331–35. https://doi.org/10.1016/j.febslet.2005.12.017.Full Text Link to Item
-
Keltner, John L., Chris A. Johnson, Richard A. Levine, Juanjuan Fan, Kimberly E. Cello, Michael A. Kass, and Mae O. Gordon. “Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.” Arch Ophthalmol 123, no. 9 (September 2005): 1201–6. https://doi.org/10.1001/archopht.123.9.1201.Full Text Link to Item
-
Brandt, James D., Julia A. Beiser, Mae O. Gordon, Michael A. Kass, and Michael A. Ocular Hypertension Treatment Study (OHTS) Group. “Central corneal thickness and measured IOP response to topical ocular hypotensive medication in the Ocular Hypertension Treatment Study.” Am J Ophthalmol 138, no. 5 (November 2004): 717–22. https://doi.org/10.1016/j.ajo.2004.07.036.Full Text Link to Item
-
Coleman, Anne L., Mae O. Gordon, Julia A. Beiser, Michael A. Kass, and Michael A. Ocular Hypertension Treatment Study. “Baseline risk factors for the development of primary open-angle glaucoma in the Ocular Hypertension Treatment Study.” Am J Ophthalmol 138, no. 4 (October 2004): 684–85. https://doi.org/10.1016/j.ajo.2004.05.030.Full Text Link to Item
-
Higginbotham, Eve J., Mae O. Gordon, Julia A. Beiser, Michael V. Drake, G Richard Bennett, M Roy Wilson, Michael A. Kass, and Michael A. Ocular Hypertension Treatment Study Group. “The Ocular Hypertension Treatment Study: topical medication delays or prevents primary open-angle glaucoma in African American individuals.” Arch Ophthalmol 122, no. 6 (June 2004): 813–20. https://doi.org/10.1001/archopht.122.6.813.Full Text Link to Item
-
Reitsamer, Herbert A., Jeffrey W. Kiel, Joseph M. Harrison, Nancy L. Ransom, and Stuart J. McKinnon. “Tonopen measurement of intraocular pressure in mice.” Exp Eye Res 78, no. 4 (April 2004): 799–804. https://doi.org/10.1016/j.exer.2003.11.018.Full Text Link to Item
-
Tahzib, N. G., N. L. Ransom, H. A. Reitsamer, and S. J. McKinnon. “Alpha-fodrin is cleaved by caspase-3 in a chronic ocular hypertensive (COH) rat model of glaucoma.” Brain Research Bulletin 62, no. 6 (February 2004): 491–95. https://doi.org/10.1016/s0361-9230(03)00083-2.Full Text
-
Mayo, George L., Robert F. Melendez, Neeru Kumar, Stuart J. McKinnon, and Randolph D. Glickman. “Antibody-targeted photodynamic therapy.” Am J Ophthalmol 136, no. 6 (December 2003): 1151–52. https://doi.org/10.1016/s0002-9394(03)00675-5.Full Text Link to Item
-
McKinnon, Stuart J. “Glaucoma: ocular Alzheimer's disease?” Front Biosci 8 (September 1, 2003): s1140–56. https://doi.org/10.2741/1172.Full Text Link to Item
-
Keltner, John L., Chris A. Johnson, Kimberly E. Cello, Mary A. Edwards, Shannan E. Bandermann, Michael A. Kass, Mae O. Gordon, and Mae O. Ocular Hypertension Treatment Study Group. “Classification of visual field abnormalities in the ocular hypertension treatment study.” Arch Ophthalmol 121, no. 5 (May 2003): 643–50. https://doi.org/10.1001/archopht.121.5.643.Full Text Link to Item
-
Mayo, George L., John E. Carter, and Stuart J. McKinnon. “Bilateral optic disk edema and blindness as initial presentation of acute lymphocytic leukemia.” Am J Ophthalmol 134, no. 1 (July 2002): 141–42. https://doi.org/10.1016/s0002-9394(02)01465-4.Full Text Link to Item
-
Gordon, Mae O., Julia A. Beiser, James D. Brandt, Dale K. Heuer, Eve J. Higginbotham, Chris A. Johnson, John L. Keltner, et al. “The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma.” Arch Ophthalmol 120, no. 6 (June 2002): 714–20. https://doi.org/10.1001/archopht.120.6.714.Full Text Link to Item
-
Kass, Michael A., Dale K. Heuer, Eve J. Higginbotham, Chris A. Johnson, John L. Keltner, J Philip Miller, Richard K. Parrish, M Roy Wilson, and Mae O. Gordon. “The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.” Arch Ophthalmol 120, no. 6 (June 2002): 701–13. https://doi.org/10.1001/archopht.120.6.701.Full Text Link to Item
-
McKinnon, Stuart J., Donna M. Lehman, N Grace Tahzib, Nancy L. Ransom, Herbert A. Reitsamer, Peter Liston, Eric LaCasse, Qiuhong Li, Robert G. Korneluk, and William W. Hauswirth. “Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model.” Molecular Therapy : The Journal of the American Society of Gene Therapy 5, no. 6 (June 2002): 780–87. https://doi.org/10.1006/mthe.2002.0608.Full Text
-
McKinnon, Stuart J., Donna M. Lehman, Lisa A. Kerrigan-Baumrind, Carol A. Merges, Mary Ellen Pease, Danielle F. Kerrigan, Nancy L. Ransom, et al. “Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.” Invest Ophthalmol Vis Sci 43, no. 4 (April 2002): 1077–87.Link to Item
-
Johnson, Chris A., John L. Keltner, Kimberly E. Cello, Mary Edwards, Michael A. Kass, Mae O. Gordon, Donald L. Budenz, Douglas E. Gaasterland, Elliot Werner, and Elliot Ocular Hypertension Study Group. “Baseline visual field characteristics in the ocular hypertension treatment study.” Ophthalmology 109, no. 3 (March 2002): 432–37. https://doi.org/10.1016/s0161-6420(01)00948-4.Full Text Link to Item
-
Feuer, William J., Richard K. Parrish, Joyce C. Schiffman, Douglas R. Anderson, Donald L. Budenz, Maria-Cristina Wells, Ditte J. Hess, Michael A. Kass, and Mae O. Gordon. “The Ocular Hypertension Treatment Study: reproducibility of cup/disk ratio measurements over time at an optic disc reading center.” Am J Ophthalmol 133, no. 1 (January 2002): 19–28. https://doi.org/10.1016/s0002-9394(01)01338-1.Full Text Link to Item
-
Sponsel, William E., Gianmarco Paris, Yolanda Trigo, Melanie Pena, Anke Weber, Keith Sanford, and Stuart McKinnon. “Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapy.” American Journal of Ophthalmology 133, no. 1 (January 2002): 11–18. https://doi.org/10.1016/s0002-9394(01)01286-7.Full Text
-
Brandt, J. D., J. A. Beiser, M. A. Kass, and M. O. Gordon. “Central corneal thickness in the Ocular Hypertension Treatment Study (OHTS).” Ophthalmology 108, no. 10 (October 2001): 1779–88. https://doi.org/10.1016/s0161-6420(01)00760-6.Full Text Link to Item
-
Quigley, H. A., S. J. McKinnon, D. J. Zack, M. E. Pease, L. A. Kerrigan-Baumrind, D. F. Kerrigan, and R. S. Mitchell. “Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats.” Investigative Ophthalmology & Visual Science 41, no. 11 (October 2000): 3460–66.
-
Keltner, J. L., C. A. Johnson, J. M. Quigg, K. E. Cello, M. A. Kass, and M. O. Gordon. “Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group.” Arch Ophthalmol 118, no. 9 (September 2000): 1187–94. https://doi.org/10.1001/archopht.118.9.1187.Full Text Link to Item
-
Pease, M. E., S. J. McKinnon, H. A. Quigley, L. A. Kerrigan-Baumrind, and D. J. Zack. “Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma.” Investigative Ophthalmology & Visual Science 41, no. 3 (March 2000): 764–74.
-
Gordon, M. O., and M. A. Kass. “The Ocular Hypertension Treatment Study: design and baseline description of the participants.” Arch Ophthalmol 117, no. 5 (May 1999): 573–83. https://doi.org/10.1001/archopht.117.5.573.Full Text Link to Item
-
Jacob, J. T., C. F. Burgoyne, S. J. McKinnon, T. M. Tanji, P. K. LaFleur, and E. Duzman. “Biocompatibility response to modified Baerveldt glaucoma drains.” J Biomed Mater Res 43, no. 2 (1998): 99–107. https://doi.org/10.1002/(sici)1097-4636(199822)43:2<99::aid-jbm3>3.0.co;2-g.Full Text Link to Item
-
Loewenstein, A., S. McKinnon, and C. DiBernardo. “Echographic diagnosis of scleral fold in hypotony.” Am J Ophthalmol 124, no. 2 (August 1997): 260–61. https://doi.org/10.1016/s0002-9394(14)70801-3.Full Text Link to Item
-
McKinnon, S. J. “Glaucoma, apoptosis, and neuroprotection.” Curr Opin Ophthalmol 8, no. 2 (April 1997): 28–37. https://doi.org/10.1097/00055735-199704000-00006.Full Text Link to Item
-
McKinnon, S. J., S. L. Whittenburg, and B. Brooks. “Nonequilibrium Molecular dynamics simulation of oxygen diffusion through hexadecane monolayers with varying concentrations of cholesterol.” Journal of Physical Chemistry 96, no. 25 (January 1, 1992): 10497–506. https://doi.org/10.1021/j100204a070.Full Text
-
Whittenburg, S. L., V. K. Jain, and S. J. McKinnon. “Depolarized Rayleigh scattering study of pyrimidine.” Journal of Molecular Liquids 47, no. 1–3 (January 1, 1990): 161–69. https://doi.org/10.1016/0167-7322(90)80073-S.Full Text
-
Goodman, M. A., S. J. McKinnon, V. K. Jain, and S. L. Whittenburg. “Hypersonic attenuation in simple cresols.” Journal of Physical Chemistry 93, no. 18 (January 1, 1989): 6832–35. https://doi.org/10.1021/j100355a050.Full Text
-
Whittenburg, S. L., S. J. McKinnon, V. K. Jain, and R. F. Evilia. “Depolarized Rayleigh light scattering and NMR spectroscopy of m-cresol and p-cresol.” Journal of Physical Chemistry 92, no. 14 (January 1, 1988): 4236–41. https://doi.org/10.1021/j100325a048.Full Text
-
Goodman, M. A., V. K. Jain, S. J. McKinnon, and S. L. Whittenburg. “Hypersonic attenuation in the simple amides.” Journal of Physical Chemistry 91, no. 6 (January 1, 1987): 1634–38. https://doi.org/10.1021/j100290a068.Full Text
-
Homer, S. R., S. J. McKinnon, and S. L. Whittenburg. “A series of experiments with 2-methyl-2-nitrosopropane: A physical chemistry experiment.” Journal of Chemical Education 63, no. 12 (January 1, 1986): 1103–4. https://doi.org/10.1021/ed063p1103.Full Text
-
Whittenburg, S. L., V. K. Jain, and S. J. McKinnon. “Depolarized Rayleigh scattering study of neat formamide.” Journal of Physical Chemistry 90, no. 6 (January 1, 1986): 1004–5. https://doi.org/10.1021/j100278a008.Full Text
-
-
Book Sections
-
McKinnon, S. J. “Gene Therapy in Glaucoma.” In Glaucoma: Second Edition, 1:657–65, 2015. https://doi.org/10.1016/B978-0-7020-5193-7.00064-9.Full Text
-
McKinnon, S. J. “Posterior segment changes in glaucoma.” In Garner and Klintworth’s Pathobiology of Ocular Disease, Third Edition, 433–44, 2008.
-
-
Other Articles
-
McKinnon, Stuart James. “Rats! Hyperglycemia protects against glaucoma!.” Arch Ophthalmol, October 2011. https://doi.org/10.1001/archophthalmol.2011.308.Full Text Link to Item
-
Sponsel, W. E., and S. J. McKinnon. “Brain Research Bulletin: Preface.” Brain Research Bulletin, February 15, 2004. https://doi.org/10.1016/j.brainresbull.2004.01.001.Full Text
-
-
Conference Papers
-
Hirt, Joshua, Angela Dixon, Stuart J. McKinnon, and Paloma Borrajo Liton. “Autophagy in the Neuroretina and Angle Region of DBA/2J Mice.” In Investigative Ophthalmology & Visual Science, Vol. 56. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2015.Link to Item
-
McKinnon, S. J., L. T. Kasmala, and A. L. Dixon. “Severe B- and T-Lymphocyte Immunodeficiency Caused by Rag1 Knockout Prevents Optic Nerve Axon Loss in a Mouse Glaucoma Model.” In Investigative Ophthalmology & Visual Science, Vol. 51. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2010.Link to Item
-
Samuels, B. C., S. J. McKinnon, and R. R. Allingham. “Lowering Intracranial Pressure: Developing a Model for Normal Tension Glaucoma.” In Investigative Ophthalmology & Visual Science, Vol. 51. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2010.Link to Item
-
McKinnon, S. J., and M. E. Pease. “Immunohistochemical localization of the tyrosine kinase receptor TRKB in monkey photoreceptors.” In Investigative Ophthalmology and Visual Science, Vol. 38, 1997.
-
Pease, M. E., S. J. McKinnon, D. J. Zack, and H. A. Quigley. “Localization of the neurotrophin receptor trkb in normal and glaucomatous monkey optic nerve heads.” In Investigative Ophthalmology and Visual Science, Vol. 38, 1997.
-
Jacob-LaBarre, J. T., S. J. McKinnon, and T. Tanji. “Biocompatibility response to modified Baerveldt glaucoma drains.” In Transactions of the Annual Meeting of the Society for Biomaterials in Conjunction With the International Biomaterials Symposium, Vol. 1, 1996.
-
Jacob-LaBarre, J. T., S. J. McKinnon, and T. Tanji. “Biocompatibility response to modified Baerveldt glaucoma drains.” In Investigative Ophthalmology and Visual Science, Vol. 37, 1996.
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.
